| Application no. and date | 16167534.3 (espacenet) (Federated) (European Patent Register), 20080926 | | Patent/reg. no. and date | DK/EP 3078743, 20200624 | | Publication date | 20161012 | | Priority no. and date | US 976343 P, 20070928, US 90574 P, 20080820 | | EP pub. no. and date |
EP 3078743 20161012 | | Effective date | | | Applicant/owner | Alexion Pharmaceuticals, Inc., 121 Seaport Boulevard
Boston, MA 02210, US | | Applicant ref. no. | 1559259 | | Inventor | SINHA, Uma, 808 Junipero Serra Boulevard
San Francisco, CA 94127, US,
LU, Genmin, 1439 El Camino Real Apt. 9
Burlingame, CA 94010, US,
PHILLIPS, David R., 520 Harvard Road
San Mateo, CA 94402, US,
ANDRE, Patrick, 287 Taylor Road South
Short Hills, NJ 07078, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 38/48 (2006.01) , A61P 7/04 (2006.01) , C12N 9/64 (2006.01) | | Title | ANTIDOTER TIL FAKTOR XA-INHIBITORER OG FREMGANGSMÅDER TIL ANVENDELSE AF DISSE | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | CA 2020 00044 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
